Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 367  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (129 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 »  Introduction
 »  Materials and Me...
 »  Results
 »  Discussion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed15116    
    Printed240    
    Emailed5    
    PDF Downloaded249    
    Comments [Add]    
    Cited by others 15    

Recommend this journal

 


 
ORIGINAL ARTICLE
Year : 2005  |  Volume : 53  |  Issue : 1  |  Page : 66-71

Electro-clinical characteristics and postoperative outcome of medically refractory tumoral temporal lobe epilepsy


Department of Neurology, R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India

Date of Acceptance05-Nov-2004

Correspondence Address:
Kurupath Radhakrishnan
Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum - 695 011, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.15061

Rights and Permissions

 » Abstract 

BACKGROUND: Very few studies have specifically addressed surgical treatment and outcome of patients with tumor-related temporal lobe epilepsy (TLE). AIM: To define the postoperative seizure outcome and the factors that influenced the outcome of patients with tumor-related TLE. MATERIALS AND METHODS: We selected patients whose surgical pathology revealed a temporal lobe neoplasm and who had completed > 1 year of postoperative follow-up. We reviewed the clinical, EEG, radiological and pathological data, and the seizure outcome of these patients and assessed the factors that influenced the outcome. RESULTS: Out of the 409 patients who underwent surgery for refractory TLE during the 8-year study period, there were 34 (8.3%) patients with temporal lobe neoplasms. The median age at surgery was 20 years and the median duration of epilepsy prior to surgery was 9.0 years. MRI revealed tumor in the mesial location in 21 (61.8%) patients. Interictal and ictal epileptiform EEG abnormalities were localized to the side of th lesion in the majority. Mesial temporal lobe structures were included in the resection, if they were involved by the tumor; otherwise, lesionectomy alone was performed. During a median follow-up of 4 years, 27 (79%) patients were completely seizure-free. The only factor that predicted long-term seizure-free outcome was being seizure-free during the first two postoperative years. CONCLUSIONS: Our results emphasize the fact that in patients with tumoral TLE, when the seizures are medically refractory, surgery offers potential for cure of epilepsy in the majority.


Keywords: Epilepsy, temporal lobe, tumoral epilepsy, medically refractory epilepsy


How to cite this article:
Panda S, Radhakrishnan VV, Radhakrishnan K, Rao RM, Sarma SP. Electro-clinical characteristics and postoperative outcome of medically refractory tumoral temporal lobe epilepsy. Neurol India 2005;53:66-71

How to cite this URL:
Panda S, Radhakrishnan VV, Radhakrishnan K, Rao RM, Sarma SP. Electro-clinical characteristics and postoperative outcome of medically refractory tumoral temporal lobe epilepsy. Neurol India [serial online] 2005 [cited 2020 Jul 7];53:66-71. Available from: http://www.neurologyindia.com/text.asp?2005/53/1/66/15061



 » Introduction Top


More than two-thirds of carefully selected patients with medically refractory temporal lobe epilepsy (TLE) become seizure-free following surgery.[1],[2] A magnetic resonance imaging (MRI)-detected lesion is one of the most important factors that predicts the seizure outcome following epilepsy surgery.[2],[3] Although emphasis is often placed on mesial temporal sclerosis-associated TLE,[1],[2],[3] neuropathological series of surgically treated TLE have reported neoplasms in 10% to 30% of the specimens.[4],[5]

The histopathological profile of tumor-related chronic epilepsy is quite different from the usual pattern of primary brain neoplasms.[4],[5] Although low-grade tumors such as ganglioglioma and dysembryoplastic neuroepithelial tumor (DNET) account for only a very small proportion of primary brain neoplasms, they are the lesions frequently associated with tumoral refractory epilepsy.[4],[5]

Several studies have addressed the surgical treatment and outcome of patients with tumoral chronic epilepsy.[6],[7],[8],[9],[10],[11],[12],[13],[14] A majority of them have either combined a variety of neoplasms involving different brain regions,[9],[11] or have assembled a specific tumor type involving different brain locations.[7],[8] Tumor-related refractory epilepsy encompasses a heterogeneous group of temporal and extratemporal epilepsies with different pathological substrates and postoperative seizure outcomes.[5] To our knowledge, very few studies have specifically addressed the surgical treatment and outcome of tumoral TLE.[10],[12],[13],[14] This is all the more surprising because the temporal lobe is the commonest site of the neoplasms associated with medically refractory epilepsy.[5] A literature survey from the Indian subcontinent revealed no published reports which highlighted the electro-clinical profile and postoperative outcome of tumoral chronic TLE.

With the above considerations, we undertook this study to review the clinical, electroencephalographic (EEG), and radiological data of patients with tumoral TLE, who had undergone evaluation and surgery through our epilepsy program, and to define the postoperative seizure outcome of these patients and the factors that influenced the outcome.


 » Materials and Methods Top


Between March 1995 through March 2003, 409 patients underwent surgery for medically refractory TLE at our epilepsy center. The details of our presurgical evaluation protocol, which includes history, optimum 1.5T MRI, interictal scalp EEG, video-EEG monitoring with scalp/sphenoidal electrodes, and neuropsychological assessment, have been described previously.[15] None of the patients were subjected to positron emission tomography and single photon emission computed tomography or invasive EEG studies. For the purpose of this study, we selected patients whose surgical pathology revealed a temporal lobe neoplasm and who had completed 1 year of postoperative follow-up. We excluded patients in whom the indication for surgery primarily was the lesion and not refractory epilepsy.

We reviewed all the preoperative MRI films to delineate the site, size, and extent of the tumor, as well as the contrast enhancement, calcification, cystic changes and mass effect, and associated hippocampal atrophy and sclerosis. We used collateral sulcus as the boundary between the medial and lateral location of the tumor in the temporal lobe.

Standard 10-20 system of extracranial electrode placement was used with additional anterior temporal (T1 and T2) electrodes. The distribution of interictal epileptiform discharges (IEDs) during prolonged video-EEG monitoring was assessed by visual analysis of interictal EEG samples of 15 seconds every 15 minutes. We classified scalp recorded ictal EEG activity into three patterns: regular, well-modulated, 5 - 9 Hz, unilateral temporal and/or subtemporal rhythm (Type 1), polymorphic slower (<5 Hz) rhythm with broader unihemispheric distribution (Type 2), and diffuse irregular slowing in the background activity (Type 3).[16],[17] The diagnosis of the video-EEG recorded seizures as temporal was based on the well recognized semiological characteristics (such as epigastric aura, behavioral arrest, oro-alimentary and limb automatisms, dystonic limb posturing, ictal speech, and post-ictal dysphasia) along with the localization and pattern of ictal EEG discharges.[17],[18]

Surgical procedures

All surgeries were undertaken under general anesthesia. The operative procedure was tailored as warranted by the site and extent of the tumor. Intraoperative electrocorticography (ECoG) was performed during all resections undertaken after September 2001.

Pathological examination

Four-micrometer-thick histological sections were generated from 10% formalin-fixed, paraffin-embedded tissue and stained with hematoxylin and eosin.[19] For pathological diagnosis, we used the WHO definition of primary brain neoplasms.[20] While the histopathological diagnosis of ganglioglioma required an intimate mixture of neoplastic ganglion cells and neoplastic astrocytes, cystic spaces with floating neurons and oligodendroglia-like cells characterized DNET. We defined associated mesial temporal sclerosis as the loss of neuronal cell population of 30% in the CA1 sector of the hippocampal formation with or without neuronal loss and gliosis involving other mesial temporal lobe structures.[19]

Patients were regularly followed up at 3 months and 12 months after surgery and at yearly intervals thereafter. The postoperative seizure outcome at last follow-up was defined as seizure-free without antiepileptic drugs, seizure-free with antiepileptic drugs, and unfavorable outcome (seizure recurrence of any type).[15] Neuropsychological assessment and EEG were repeated according to standard protocol during each follow-up visit until 3 years.[15],[21] Postoperative MRI was undertaken only in those with seizure recurrence.

Statistical methods

We analyzed the data using the SPSS statistical package. We tested the association of different clinical, EEG and MRI characteristics with the seizure outcome at last follow-up utilizing 2-tailed t-test, Pearson's chi-square test and Fisher's exact test, as appropriate. We used standard deviation (SD) to define the dispersion.


 » Results Top


Patient characteristics

Out of the 409 patients who underwent surgery for refractory TLE during the study period, there were 34 (8.3%) patients (22 males, 12 females) with temporal lobe neoplasms. The demographic and clinical features of these patients are provided in [Table - 1]. The median age at surgery was 20.0 years (range 1.3 to 37 years), and the median duration of epilepsy prior to surgery was 9.0 (range 1 to 25) years. The antecedents included family history of seizures (3 patients), febrile seizures (5 patients) and encephalitis (1 patient). Seizure semiology suggested complex partial seizures of temporal lobe origin in all patients; in addition, secondarily generalized seizures occurred in 21 patients. Four of our patients exhibited preoperative overt psychiatric disturbances (depression with suicidal ideation, obsessive compulsive disorder in one each and conduct disorder in 2 patients).

Neuroimaging findings

Computed tomography (CT) scan was available in 10 patients, in 2 of whom CT did not identify the tumor. MRI defined the location and extent of the tumor in all patients [Table - 1]. The tumor was confined to the mesial temporal lobe in 21 patients (61.8%) and to the lateral temporal lobe in 9 patients, while in the remaining 4, the lesion involved both the mesial and lateral temporal regions. The MRI findings included cystic changes in the tumor in 15, contrast enhancement in 11, mass-effect in 6, and perilesional edema in 2 patients. Calcification in the CT and/or MRI was noted in 11 patients. Concomitant mesial temporal sclerosis was observed in 3 patients.

EEG data

Temporal IEDs were present exclusively on the side of the lesion in 24 patients. Bilateral independent temporal IEDs were seen in 7 patients. While 1 patient had extratemporal IEDs, 2 patients did not manifest any IEDs. During video-EEG monitoring, temporal intermittent rhythmic delta activity (TIRDA) ipsilateral to the tumor location was seen in 8 patients. Ictal EEG pattern was Type 2 in 18 patients and Type 1 in 14 patients [Table - 1]. No seizures were recorded in 2 patients. The mean duration of the video-EEG monitoring was 2.9 days (range 6 hours to 9 days).

Surgery

[Table - 1] lists the surgical procedures employed. While lesionectomy alone was sufficient in 5 patients, involvement of the mesial structures by the tumor necessitated either anterior temporal lobectomy with amygdalohippocampectomy (21 patients) or selective amygdalohippocampectomy (1 patient). None underwent postoperative radiotherapy. Two patients with postoperative seizure recurrence required repeat surgery to resect residual lesions.

Pathology

The distribution of patients according to pathological diagnosis is provided in [Figure - 1]. Ganglioglioma [Figure - 2] was the commonest tumor type (23 patients). Low-grade gliomas and DNET [Figure - 3] were diagnosed in 8 and 3 patients, respectively. The interesting association of DNET with melanotic differentiation has been reported previously in 1 of our patients.[22]

Seizure outcome

During the median duration of follow-up of 4 (range 1-9) years, 27 of 34 patients (79.0%) were completely seizure-free at last follow-up; antiepileptic drugs could be successfully discontinued in 11 (32%) of them [Table - 1]. The seizure-free outcome at 2 years (23/29, 79.3%) and at 5 years (9/12, 75%) did not differ (P=1.000). Seven patients continued to have postoperative seizures, although 5 of them experienced >75% seizure reduction. Two patients continued to have auras, which did not impair the activities of daily living.

Complications

No patient died. Long-term morbidity in the form of hemiparesis and hemianopia occurred in 3 patients each. Fifteen patients had quadrantinopic field defect, which did not bother them. None of our patients exhibited any significant postoperative aggravation of psychiatric disturbances. Residual lesion was detected in 5 out of 8 patients who underwent postoperative MRI.

Predictors of outcome

The attributes of the patients with excellent and unfavorable seizure outcomes are compared in [Table - 2]. Age at surgery, duration of epilepsy prior to surgery, preoperative interictal and ictal EEG data, distribution of neuropsychological deficit and histopathological tumor type did not influence the outcome. While 25 of 27, (92.6%) patients who were seizure-free at last follow-up did not have seizures in the first postoperative year, only 3 of 7 (42.9%) with seizure recurrence were seizure-free during the first postoperative year. The difference (49.7%, 95% confidence interval 11.7% - 87.7%) was significant (P=0.01). The difference was even more significant for those who remained seizure-free for two years (67.7%, 33.5%-99.1%, P=<0.001). The seizure outcome of those with tumor only (25/32, 80.6%) and of those with tumor plus mesial temporal sclerosis (dual pathology) (2/3, 66.7%) did not differ (P=0.511). Similarly, there was no significant difference (P=0.317) in the seizure outcome between the patients who underwent standard anterior temporal lobectomy (10/11, 90.9%), extended anterior temporal lobectomy (10/15, 66.7%) or lesionectomy (5/6, 83.3%). Tumor location, whether mesial (16/21, 76.2%) or lateral (7/9, 77.8%), did not influence the seizure outcome (P=1.000). Seizure-free outcome was seen in all 3 patients with post-resection IEDs (100%) compared to 5 of 8 patients with no post-resection IEDs (62.5%) in the ECoG (P=0.49).


 » Discussion Top


Tumor-related epilepsy constitutes about one-third of patients with medically refractory epilepsy.[4],[5] A number of studies have investigated the clinical features, electrographic correlates and postoperative seizure outcome of patients with chronic epilepsy due to tumors of different histological types located at different brain regions.[6],[7],[8],[9],[10],[11],[12],[13],[14],[23] The electro-clinical features, presurgical evaluation strategy, surgical treatment and outcome differ considerably between temporal and extratemporal epilepsies.[5] Only very few studies have specifically addressed the clinical, electrographic and surgical outcome of tumoral TLE,[10],[12],[13],[14] and none of them are from India. This prompted us to review the clinical, electrophysiological and radiological data, and seizure outcome of patients with tumor-related TLE who had undergone surgery in our Epilepsy Program.

Because of differences in the selection and histopathological criteria, the distribution of the neoplasms according to type has varied widely between series of patients with tumoral chronic epilepsy.[4],[5],[9],[24] Nevertheless, in the majority of the series, as in ours, ganglioglioma is the commonest tumor type, followed by other low-grade gliomas and DNET.[5] A majority of the patients with tumoral refractory epilepsy, as in our series, gets recruited for surgery in early adult life after having had refractory seizures for a decade or more.[5],[8],[9]

Among our 34 patients with tumoral TLE, during a median postoperative follow-up period of 4 years, seizure freedom was achieved in nearly 80% of patients; one-third of them were completely free of AEDs. Over 90% of our patients had more than 75% seizure reduction at last follow-up. Among the 68 patients, who had undergone evaluation and surgery for refractory epilepsy in the Yale University Epilepsy Program,[10] during a mean period of follow-up of 9 years after surgical intervention, 65% of patients were seizure-free and 87% had substantial seizure reduction. Our results are in agreement with those from epilepsy surgery centers in the West [10],[12],[13],[14] and emphasize the fact that in patients with tumoral TLE, when the seizures are medically refractory, surgery offers potential cure of epilepsy in the majority. Although no systematic study has so far been conducted comparing patients with tumors in temporal and extratemporal locations, tumoral TLE is generally considered to have a better seizure-free outcome following surgery.[5]

In the Yale University series of patients with tumoral TLE,[10] a better postoperative seizure outcome was found in patients with early surgical intervention and complete tumor resection. However, other studies have failed to find a significant association between age at surgery and postoperative seizure outcome.[25],[26] While incomplete tumor resection was an important cause of poor postoperative seizure outcome in some studies,[9],[10],[27] the presence of residual tumor did not significantly influence the seizure outcome in other studies.[8],[28] In the present series of patients with tumoral TLE, our inability to find a significant association of these variables with postoperative seizure outcome may be a reflection of the small number of patients who had an unfavorable outcome. Moreover, considering the financial constraints of the patients and the benign nature of the neoplasms resected, we undertook postoperative MRI only in those with seizure recurrence. Early successful surgical intervention will minimize the adverse medical, behavioral and psychosocial consequences on longstanding refractory epilepsy.[15] The objective of any brain tumor surgery is the complete resection of the lesion, if feasible.[5],[29] As we observed, several epilepsy surgery outcome studies have shown that long-term seizure control is best when the patient is seizure-free during the first two years following surgery.[23],[30],[31]

In a comparative analysis of the distribution of the IEDs as seen in the scalp EEG in TLE due to hippocamal sclerosis versus mesial temporal lobe tumors, Hamer et al[32] observed more widespread distribution of IEDs in tumor patients compared to the restricted spiking zone at the anterior temporal region in patients with hippocampal sclerosis. The presence of IEDs over the contralateral temporal lobe did not affect the seizure outcome in our patients. The patterns of scalp-recorded ictal EEG patterns have been correlated with the etiological subtypes of TLE.[16],[17] Whereas a localized well-modulated, subtemporal theta frequency rhythm (Type 1) signified hippocampal sclerosis, a polymorphic slower rhythm with broader hemispheric distribution was more often associated with other causes.[16],[17] In view of the poor predictive value of the EEG abnormalities in patients with tumor-related TLE, the need of long-term video-EEG monitoring in such patients has been questioned.[8] Ictal monitoring, however, is the only method to document the patient's habitual seizures and to exclude non-epileptic behavioral events. Some studies have found better seizure outcome in patients with tumor who underwent resection of the epileptogenic cortex in addition to the tumor, guided by ECoG.[11],[26],[33] However, in an analysis of the postoperative seizure outcome among 60 children with tumor-related refractory seizures, favorable seizure outcome was achieved in the majority without the assistance of intraoperative ECoG.[27] Intraoperative ECoG was done in 13 of our patients to guide the tumor resection. There was no difference in the seizure outcome among those operated with and without ECoG.

Although an increased occurrence of psychosis with predominant depressive and paranoid features following surgical treatment of ganglioglioma was initially postulated over 40 years ago,[34] recent temporal lobectomy series have failed to substantiate this observation.[35],[36] We did not observe major psychosis in the postoperative period in any one of them or in those with other neoplasms. However, the psychiatric disturbances observed preoperatively in 4 patients persisted in the postoperative period without significant aggravation.

Our results are in agreement with prior reports regarding the imaging findings and the optimal surgical strategy.[5] A majority of our patients had removal of the mesial temporal lobe structures because, as suggested by the MRI and intraoperative findings, they were involved by the tumor. When the lesion was confined to the lateral temporal region, we did lesionectomy alone. In patients with tumoral TLE, in the absence of tumor invasion of the hippocampus and/or secondary hippocampal sclerosis, inclusion of mesial structures in the resection is unnecessary, as it has not been shown to improve seizure outcome.[5],[8],[10],[37]

 
 » References Top

1.Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003;60:538-47.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Radhakrishnan K, So EL, Silbert PL, Jack CR Jr, Cascino GD, Sharbrough FW, et al. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: A multivariate study. Neurology 1998;51:465-71.  Back to cited text no. 2  [PUBMED]  
3.McIntosh AM, Wilson SJ, Berkovic SF. Seizure outcome after temporal lobectomy: Current research practice findings. Epilepsia 2001;42:1288-307.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Wolf HK, Wiestler OD. Surgical pathology of chronic epileptic seizure disorders. Brain Pathol 1993;3:371-80.  Back to cited text no. 4  [PUBMED]  
5.Wetjen NM, Radhakrishnan K, Cohen-Gadol AA, Cascino GD. Resective surgery of neoplastic lesions for epilepsy. In: Shorvon SD, Perucca E, Fish DR, Dodson WE, editors. The Treatment of Epilepsy. Oxford: Blackwell Science; 2004. p. 728-41.  Back to cited text no. 5    
6.Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, et al. Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg 1993;79:867-73.  Back to cited text no. 6  [PUBMED]  
7.Celli P, Scarpinati M, Nardacci B, Cervoni L, Cantore GP. Gangliogliomas of the cerebral hemispheres. Report of 14 cases with long-term follow-up and review of literature. Acta Neurochir 1993;125:52-7.  Back to cited text no. 7  [PUBMED]  
8.Morris HH, Matkovic Z, Estes ML, Prayson RA, Comair YG, Turnbull J, et al. Ganglioglioma and intractable epilepsy: Clinical and neuropsychologic features and predictors of outcome after surgery. Epilepsia 1998;39:307-13.  Back to cited text no. 8  [PUBMED]  
9.Morris HH, Estes ML, Gilmore R, Van Ness PC, Barnett GH, Turnbull J. Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia 1993;34:1038-43.  Back to cited text no. 9  [PUBMED]  
10.Zaatreh MM, Firlik KS, Spencer DD, Spencer SS. Temporal lobe tumoral epilepsy. Characteristics and predictors of surgical outcome. Neurology 2003;61:636-41.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]
11.Beger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA. Low-grade gliomas associated with intractable epilepsy: Seizure outcome utilizing electrocortcography during tumor resection. J Neurosurg 1993;79:62-9.  Back to cited text no. 11    
12.Hennessy MJ, Elwes RDC, Honavar M, Rabe-Hesketh S, Binnie CD, Polkey CE. Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions. J Neurol Neurosurg Psychiatry 2001;70:450-8.  Back to cited text no. 12    
13.Arseni C, Petrovici IN. Epilepsy in temporal lobe tumours. Eur Neurol 1971;5:201-4.  Back to cited text no. 13    
14.Jorge CL, Nagahashi-Marie SK, Pedreira CC, Rosemberg S, Valerio RM, Valente KD, et al. Clinical characteristics and surgical outcome of patients with temporal lobe tumors and epilepsy. Arq Neuropsiquiatr 2000;58:1002-8.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]
15.Rao MB, Radhakrishnan K. Is epilepsy surgery possible in countries with limited resources? Epilepsia 2000;41:S31-4.  Back to cited text no. 15  [PUBMED]  
16.Assaf BA, Ebersole JS. Visual and quantitative ictal EEG predictors of outcome after temporal lobectomy. Epilepsia 1999;40:52-61.  Back to cited text no. 16  [PUBMED]  
17.Sylaja PN, Radhakrishnan K. The role of scalp EEG in the presurgical evaluation of patients with medically refractory temporal lobe epilepsy. Am J END Technol 2001;41:116-35.  Back to cited text no. 17    
18.Williamson PD, Thadani VM, French JA, Darcy TM, Mattson RH, Spencer SS, et al. Medial temporal lobe epilepsy: Videotape analysis of objective clinical characteristics. Epilepsia 1998;39:1182-8.  Back to cited text no. 18    
19.Radhakrishnan VV, Rao MB, Radhakrishnan K, Thomas SV, Nayak SD, Santoshkumar B, et al. Pathology of temporal lobe epilepsy: An analysis of 100 consecutive surgical specimens from patients with medically refractory epilepsy. Neurol India 1999;47:196-201.  Back to cited text no. 19    
20.Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumors of the Central Nervous System, 2nd Ed., Berlin: Springer Verlag; 1993.  Back to cited text no. 20    
21.Alexander A, Thomas SV, Radhakrishnan K. The role of neuropsychological assessment in the presurgical evaluation and postsurgical follow-up of patients with medically refractory temporal lobe epilepsy. In: Radhakrishnan K. editor. Medically Refractory Epilepsy. Trivandrum, India: Sree Chitra Tirunal Institute for Medical Sciences and Technology; 1999. p. 159-63.  Back to cited text no. 21    
22.Elizabeth J, Bhaskara RM, Radhakrishnan VV, Radhakrishnan K, Thomas SV. Melanotic differentiation in dysembryoplastic neuroepithelial tumor. Clin Neuropathol 2000;19:38-40.  Back to cited text no. 22  [PUBMED]  
23.Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, et al. The spectrum of long-term epilepsy-associated tumors: Long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003;44:822-30.  Back to cited text no. 23    
24.Britton JW, Cascino GD, Sharbrough FW, Kelly PJ. Low grade glial neoplasms and intractable partial epilepsy. Efficacy of surgical treatment. Epilepsia 1994;35:1130-5.  Back to cited text no. 24  [PUBMED]  
25.Cascino GD, Kelly PJ, Sharbrough FW, Hulihan JF, Hirschorn KA, Trenerry MR. Long-term follow-up of stereotactic lesionectomy in partial epilepsy: Predictive factors and electroencephalographic results. Epilepsia 1992;33:639-44.  Back to cited text no. 25  [PUBMED]  
26.Jennum P, Dhuna A, Davies K, Fiol M, Maxwell R. Outcome of resective surgery for intractable partial epilepsy guided by subdural electrode arrays. Acta Neurol Scand 1993;87:434-7.  Back to cited text no. 26  [PUBMED]  
27.Packer RJ, Sutton LN, Patel KM, Duhaime AC, Schiff S, Weinstein SR, et al. Seizure control following tumor surgery for childhood cortical low-grade gliomas. J Neurosurg 1994;80:998-1002.  Back to cited text no. 27    
28.Kirkpatrick PJ, Honavar M, Janota I, Polkey CE. Control of temporal lobe epilepsy following en bloc resection of low-grade tumors. J Neurosurg 1993;78:19-25.  Back to cited text no. 28  [PUBMED]  
29.Schaller B, Rüegg SJ. Brain tumor and seizures: Pathophysiology and its implications for treatment revisited. Epilepsia 2003;44:1223-32.  Back to cited text no. 29    
30.Garcia PA, Barbaro NM, Laxer KD. The prognostic value of postoperative seizures following epilepsy surgery. Neurology 1991;41:1511-2.  Back to cited text no. 30  [PUBMED]  
31.Radhakrishnan K, So EL, Silbert PL, Cascino GD, Marsh WR, Cha RH, et al. Prognostic implications of seizure recurrence in the first year after anterior temporal lobectomy. Epilepsia 2003;44:77-80.  Back to cited text no. 31  [PUBMED]  [FULLTEXT]
32.Hamer HM, Najm I, Mohamed A, Wyllie E. Interictal epileptiform discharges in temporal lobe epilepsy due to hippocampal sclerosis versus mesial temporal lobe tumors. Epilepsia 1999;40:1261-8.  Back to cited text no. 32  [PUBMED]  
33.Pilcher WH, Silbergeld DL, Berger MS, Ojemann GA. Intraoperative electrocorticography during tumor resection: Impact on seizure outcome in patients with gangliogliomas. J Neurosurg 1993;78:891-902.  Back to cited text no. 33  [PUBMED]  
34.Taylor DC, Falconer MD. Clinical, socioeconomic and psychological changes after temporal lobectomy for epilepsy. Br J Psychiatry 1968;114:1247-61.  Back to cited text no. 34    
35.Mace CJ, Trimble MR. Psychosis following temporal lobe surgery: A report of six cases. J Neurol Neurosurg Psychiatry 1991;54:639-44.  Back to cited text no. 35  [PUBMED]  
36.Leinonen E, Tuunainen A, Lepola U. Postoperative psychosis in epileptic patients after temporal lobectomy. Acta Neurol Scand 1994;90:394-9.  Back to cited text no. 36  [PUBMED]  
37.Fried I, Kim JH, Spencer DD. Limbic and neocortical gliomas associated with seizures: A distinct clinicopathological group. Neurosurg 1994;34:815-23.  Back to cited text no. 37  [PUBMED]  [FULLTEXT]


Figures

[Figure - 1], [Figure - 2], [Figure - 3]

Tables

[Table - 1], [Table - 2]

This article has been cited by
1 Surgery for “Long-term epilepsy associated tumors (LEATs)”: Seizure outcome and its predictors
Ashalatha Radhakrishnan,Mathew Abraham,George Vilanilam,Ramshekhar Menon,Deepak Menon,Hardeep Kumar,Ajith Cherian,Neelima Radhakrishnan,Chandrashekharan Kesavadas,Bejoy Thomas,Sankara P. Sarma,Sanjeev V. Thomas
Clinical Neurology and Neurosurgery. 2016; 141: 98
[Pubmed] | [DOI]
2 Clinical characteristics, surgical and neuropsychological outcomes in drug resistant tumoral temporal lobe epilepsy
Sangeeta Ravat,Vivek Iyer,Dattatraya Muzumdar,Urvashi Shah,Pranjali Pradhan,Neeraj Jain,Yogesh Godge
International Journal of Surgery. 2015;
[Pubmed] | [DOI]
3 Outcome of lesionectomy in medically refractory epilepsy due to non-mesial temporal sclerosis (non-MTS) lesions
Vikas Dhiman,Sudhanva Rao,Sanjib Sinha,Arivazhagan Arimappamagan,Anita Mahadevan,Rose Dawn Bharath,Jitender Saini,R. Jamuna,J. Keshav Kumar,Shobhini L. Rao,Bangalore A. Chandramouli,Parthasarathy Satishchandra,Susarla K. Shankar
Clinical Neurology and Neurosurgery. 2013;
[Pubmed] | [DOI]
4 Factors associated with seizure freedom in the surgical resection of glioneuronal tumors
Dario J. Englot,Mitchel S. Berger,Nicholas M. Barbaro,Edward F. Chang
Epilepsia. 2012; 53(1): 51
[Pubmed] | [DOI]
5 Intractable epilepsy in paralimbic World Health Organization Grade II gliomas: should the hippocampus be resected when not invaded by the tumor?
Fadi Ghareeb,Hugues Duffau
Journal of Neurosurgery. 2012; 116(6): 1226
[Pubmed] | [DOI]
6 Intractable epilepsy in paralimbic Word Health Organization Grade II gliomas: Should the hippocampus be resected when not invaded by the tumor? - Clinical article
Ghareeb, F. and Duffau, H.
Journal of Neurosurgery. 2012; 116(6): 1226-1234
[Pubmed]
7 Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors
Englot, D.J. and Han, S.J. and Berger, M.S. and Barbaro, N.M. and Chang, E.F.
Neurosurgery. 2012; 70(4): 921-927
[Pubmed]
8 Factors associated with seizure freedom in the surgical resection of glioneuronal tumors
Englot, D.J. and Berger, M.S. and Barbaro, N.M. and Chang, E.F.
Epilepsia. 2012; 53(1): 51-57
[Pubmed]
9 Predictors of seizure freedom after resection of supratentorial low-grade gliomas : A review
Dario J. Englot, Mitchel S. Berger, Nicholas M. Barbaro, Edward F. Chang
Journal of Neurosurgery. 2011; 115(2): 240
[VIEW] | [DOI]
10 Association between neuroepithelial tumors and microscopic focal cortical dysplasia in patients with pharmacoresistant temporal lobe epilepsy [Asociación de tumores neuroepiteliales y displasia cortical focal microscópica en pacientes con epilepsia del lóbulo temporal fármaco resistente]
Estupiñán-Díaz, B. and Morales-Chacón, C.L. and García-Maeso, I. and Lorigados-Pedre, C.L. and Salazar-Rodríguez, S. and Gómez, H. and Trápaga-Quincoses, O. and Hidalgo-Portal, L. and Báez-Martín, M. and Gómez-Lotti, A. and Sánchez-Coroneaux, A.
Revista Ecuatoriana de Neurologia. 2009; 18(3)
[Pubmed]
11 Brain tumors in patients with intractable epilepsy: A clinicopatholoeic study of 35 cases
Sun, F.-K., Piao, Y.-S., Wang, W., Chen, L., Wei, L.-F., Yang, H., Lu, D.-H.
Chinese Journal of Pathology. 2009; 38(3): 1-2
[Pubmed]
12 Focal cortical resections for the treatment of extratemporal epilepsies in children
Ramesha, K., Radhakrishnan, K.
Journal of Pediatric Neurosciences. 2008; 3(1 SUPPL): 1-2
[Pubmed]
13 Seizure characteristics and control following resection in 332 patients with low-grade gliomas
Edward F. Chang, Matthew B. Potts, G. Evren Keles, Kathleen R. Lamborn, Susan M. Chang, Nicholas M. Barbaro, Mitchel S. Berger
Journal of Neurosurgery. 2008; 108(2): 227
[VIEW] | [DOI]
14 Brain tumors and epilepsy
Christian Brogna, Santiago Gil Robles, Hugues Duffau
Expert Review of Neurotherapeutics. 2008; 8(6): 941
[VIEW] | [DOI]
15 Outcome of adult patients with temporal lobe tumours and medically refractory focal epilepsy
R. Bauer, J. Dobesberger, C. Unterhofer, I. Unterberger, G. Walser, G. Bauer, E. Trinka, M. Ortler
Acta Neurochirurgica. 2007; 149(12): 1211
[VIEW] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow